Search research articles
Contact Us
Filters
Showing results (111-120 of 130) with videos related to
Page
of 13
Sort By:
Cell Death & Disease
|
July 13, 2026
MARCKS as a mediator and target for pathological tunneling nanotubes between patient-derived glioblastoma cells and astrocytes
Lauren C Nassour-Caswell, Mayada Ahmed, Shane T Rich-New, et al.
Oncogene
|
October 20, 2020
A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma
Nicholas J Eustace, Joshua C Anderson, Jason M Warram, et al.
International Journal of Molecular Sciences
|
October 16, 2025
A Novel Serum-Free Triculture Model of Glioblastoma, Astrocytes, and Macrophages
Hasan Alrefai, Lauren C Nassour-Caswell, Manoj Kumar, et al.
Oncogene
|
December 20, 2025
Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients
Charlotte Andrieu, Jojanneke Stoof, Dalal AlSultan, et al.
Breast Cancer Research and Treatment
|
November 3, 2012
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours
Brigid C Browne, Alex J Eustace, Susan Kennedy, et al.
Plos One
|
March 15, 2023
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
Sandra Roche, Patricia Gaule, Deirdre Winrow, et al.
Therapeutic Advances in Medical Oncology
|
February 18, 2020
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Alexandra Canonici, Alacoque L Browne, Mohamed F K Ibrahim, et al.
Cancer Treatment and Research Communications
|
April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer
Aoife Carr, Jonathan A Coulter, Julie Workman, et al.
British Journal of Cancer
|
July 28, 2023
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy
Nicola Gaynor, Alfonso Blanco, Stephen F Madden, et al.
International Journal of Oncology
|
April 4, 2019
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma
Nicholas J Eustace, Joshua C Anderson, Catherine P Langford, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 130) with videos related to
Sort By:
Page
of 13
Cell Death & Disease
|
July 13, 2026
MARCKS as a mediator and target for pathological tunneling nanotubes between patient-derived glioblastoma cells and astrocytes
Lauren C Nassour-Caswell, Mayada Ahmed, Shane T Rich-New, et al.
Oncogene
|
October 20, 2020
A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma
Nicholas J Eustace, Joshua C Anderson, Jason M Warram, et al.
International Journal of Molecular Sciences
|
October 16, 2025
A Novel Serum-Free Triculture Model of Glioblastoma, Astrocytes, and Macrophages
Hasan Alrefai, Lauren C Nassour-Caswell, Manoj Kumar, et al.
Oncogene
|
December 20, 2025
Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients
Charlotte Andrieu, Jojanneke Stoof, Dalal AlSultan, et al.
Breast Cancer Research and Treatment
|
November 3, 2012
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours
Brigid C Browne, Alex J Eustace, Susan Kennedy, et al.
Plos One
|
March 15, 2023
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
Sandra Roche, Patricia Gaule, Deirdre Winrow, et al.
Therapeutic Advances in Medical Oncology
|
February 18, 2020
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Alexandra Canonici, Alacoque L Browne, Mohamed F K Ibrahim, et al.
Cancer Treatment and Research Communications
|
April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer
Aoife Carr, Jonathan A Coulter, Julie Workman, et al.
British Journal of Cancer
|
July 28, 2023
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy
Nicola Gaynor, Alfonso Blanco, Stephen F Madden, et al.
International Journal of Oncology
|
April 4, 2019
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma
Nicholas J Eustace, Joshua C Anderson, Catherine P Langford, et al.
Page
of 13